to get you to sell your shares in GALE. He does not tell you that Roche's new drug is and will not be in competition with neuvax. He knows this and yet will not offer this information in his posts. Why? Is telling a half truth not he same as telling an untruth? Monty you simply are operating on a different level.........
To add more to your rebuttal to monty3card's mis-information, he did not tell that Roche's new breat cancer drug can only treat the high HER2 type of breast cancer which only affects a small number of patients. This new drug has to work in connnation with Herceptin. This combine treatment will cost around $15,000 for each injection. And it can only extent patients' survival by 6 months according to FDA reports.
As for NeuVax, it is most effective in treating breast cancer with low to medium HER2 expressions. The number of patients with these two types of breast cancer is much higher that the High HER2 expression type.
NeuVax is much cheaper and it is effective in prolong patients' lives for 5 years!
Indulgeron: I have added this monty3card on my bashers list 3 and I have put this character on "Ignore" !